EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $1,849,620,000 | +291.2% | 14,057 | +50.2% | 0.00% | – |
Q3 2020 | $472,809,000 | +136.2% | 9,357 | +122.8% | 0.00% | – |
Q2 2020 | $200,214,000 | +8597.4% | 4,200 | +6462.5% | 0.00% | – |
Q3 2019 | $2,302,000 | +15.7% | 64 | 0.0% | 0.00% | – |
Q2 2019 | $1,989,000 | – | 64 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 1,123,630 | $55,047,000 | 23.98% |
Opaleye Management Inc. | 315,550 | $15,459,000 | 4.10% |
RA Capital Management | 2,162,671 | $105,949,000 | 3.35% |
Board of Trustees of The Leland Stanford Junior University | 265,670 | $13,015,000 | 2.63% |
Cormorant Asset Management, LP | 1,100,000 | $53,889,000 | 2.50% |
Parkman Healthcare Partners LLC | 81,085 | $3,972,000 | 1.84% |
EAM Global Investors LLC | 38,535 | $1,888,000 | 1.10% |
Redmile Group, LLC | 689,478 | $33,778,000 | 0.95% |
Perceptive Advisors | 686,922 | $33,652,000 | 0.88% |
EAM Investors, LLC | 55,532 | $2,721,000 | 0.84% |